EPITOME THERAPEUTICS Trademark
Trademark Overview
On Tuesday, November 26, 2024, a trademark application was filed for EPITOME THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EPITOME THERAPEUTICS trademark a serial number of 79415488. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, May 20, 2025. This trademark is owned by European Molecular Biology Laboratory. The EPITOME THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals for genetic diseases and diseases associated to altered gene expression; biotechnology-formed genes for use in the manufacture of pharmaceuticals and therapeutics.
Medical services; medical diagnostic services; medical services in the field of personalized medicine.
Research in the field of gene editing technology and epigenetics; research and development in the pharmaceutical and biotechnology fields; biotechnology research.
General Information
Serial Number | 79415488 |
Word Mark | EPITOME THERAPEUTICS |
Filing Date | Tuesday, November 26, 2024 |
Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
Status Date | Tuesday, May 20, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceuticals for genetic diseases and diseases associated to altered gene expression; biotechnology-formed genes for use in the manufacture of pharmaceuticals and therapeutics. |
Indication of Colors claimed | Black, blue, turquoise, petrol blue |
Goods and Services | Medical services; medical diagnostic services; medical services in the field of personalized medicine. |
Goods and Services | Research in the field of gene editing technology and epigenetics; research and development in the pharmaceutical and biotechnology fields; biotechnology research. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 30, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 30, 2025 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 30, 2025 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | European Molecular Biology Laboratory |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | DE |
Trademark Events
Event Date | Event Description |
Thursday, January 30, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Monday, February 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, May 19, 2025 | ASSIGNED TO EXAMINER |
Monday, February 3, 2025 | APPLICATION FILING RECEIPT MAILED |
Tuesday, May 20, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, May 21, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |